New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
A new immunologic and endocrine syndrome

A new immunologic and endocrine syndrome

by University of MontrealThese mice are twin, except that the left mouse is normal whereas the Armc5 gene has been invalidated by genetic knockout in the right mouse. The mutated mouse is smaller
Breakthroughs March 25,2024
A new immunologic and endocrine syndrome

A new immunologic and endocrine syndrome

by University of MontrealThese mice are twin, except that the left mouse is normal whereas the Armc5 gene has been invalidated by genetic knockout in the right mouse. The mutated mouse is smaller
Breakthroughs March 25,2024
Baseline findings among hospitalized mucormycosis patients: A multicentric ambispective cohort study in India

Baseline findings among hospitalized mucormycosis patients: A multicentric ambispective cohort study in India

FEBRUARY 6, 2024by Tsinghua University PressDirected acyclic graph demonstrating the relationship between potential risk factors of mortality due to mucormycosis. Credit: Dr. Rizwan Suliankatchi Abdul
Breakthroughs March 25,2024
Baseline findings among hospitalized mucormycosis patients: A multicentric ambispective cohort study in India

Baseline findings among hospitalized mucormycosis patients: A multicentric ambispective cohort study in India

FEBRUARY 6, 2024by Tsinghua University PressDirected acyclic graph demonstrating the relationship between potential risk factors of mortality due to mucormycosis. Credit: Dr. Rizwan Suliankatchi Abdul
Breakthroughs March 25,2024
Combination drug activates calcium channels to trigger deadly influx of calcium ions inside tumor cells

Combination drug activates calcium channels to trigger deadly influx of calcium ions inside tumor cells

JANUARY 29, 2024byWileyCredit:Angewandte Chemie International Edition(2024). DOI: 10.1002/anie.202317578Calcium ions are essential for cells, but can be toxic in higher concentration
Oncology March 25,2024
Combination drug activates calcium channels to trigger deadly influx of calcium ions inside tumor cells

Combination drug activates calcium channels to trigger deadly influx of calcium ions inside tumor cells

JANUARY 29, 2024byWileyCredit:Angewandte Chemie International Edition(2024). DOI: 10.1002/anie.202317578Calcium ions are essential for cells, but can be toxic in higher concentration
Oncology March 25,2024
A new vaccine that alters senescent cells in a way that pushes the immune system into removing them

A new vaccine that alters senescent cells in a way that pushes the immune system into removing them

by Bob Yirka , Medical XpressFig. 1: GPNMB is a potential candidate of seno-antigen. Credit: DOI: 10.1038/s43587-021-00151-2A team of researchers affiliated with a large number of institutions in Japa
Geriatrics March 25,2024
A new vaccine that alters senescent cells in a way that pushes the immune system into removing them

A new vaccine that alters senescent cells in a way that pushes the immune system into removing them

by Bob Yirka , Medical XpressFig. 1: GPNMB is a potential candidate of seno-antigen. Credit: DOI: 10.1038/s43587-021-00151-2A team of researchers affiliated with a large number of institutions in Japa
Geriatrics March 25,2024
How one inflammatory disorder exacerbates another

How one inflammatory disorder exacerbates another

by Katherine Unger Baillie,University of PennsylvaniaInflammation in the gums can increase susceptibility to other forms of inflammation, such as arthritis, through changes to immune cell precur
Immunology & Rheumatology March 25,2024
How one inflammatory disorder exacerbates another

How one inflammatory disorder exacerbates another

by Katherine Unger Baillie,University of PennsylvaniaInflammation in the gums can increase susceptibility to other forms of inflammation, such as arthritis, through changes to immune cell precur
Immunology & Rheumatology March 25,2024
A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint
Oncology March 25,2024
A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint
Oncology March 25,2024
Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

by Ehime UniversityMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Multiple myeloma is still an incurable hematological ma
Oncology March 25,2024
Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

by Ehime UniversityMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Multiple myeloma is still an incurable hematological ma
Oncology March 25,2024
Using phages to eradicate Pseudomonas aeruginosa infections

Using phages to eradicate Pseudomonas aeruginosa infections

FEBRUARY 21, 2024byUniversity of LiverpoolPhage cocktail screening against 551 clinical isolates. Percentage of isolates susceptible (black—complete lysis), intermediate (pink—incomplete lysis)
Public Health & Prevention March 25,2024
Using phages to eradicate Pseudomonas aeruginosa infections

Using phages to eradicate Pseudomonas aeruginosa infections

FEBRUARY 21, 2024byUniversity of LiverpoolPhage cocktail screening against 551 clinical isolates. Percentage of isolates susceptible (black—complete lysis), intermediate (pink—incomplete lysis)
Public Health & Prevention March 25,2024
Advancing the generation of in-vivo chimeric lungs in mice using rat-derived stem cells

Advancing the generation of in-vivo chimeric lungs in mice using rat-derived stem cells

JANUARY 5, 2024byNara Institute of Science and TechnologyA rat embryonic stem cells derived lung generated within a mouse body stained with epithelial cells (labeled with E-cadherin, shown in gr
Pulmonology March 25,2024
Advancing the generation of in-vivo chimeric lungs in mice using rat-derived stem cells

Advancing the generation of in-vivo chimeric lungs in mice using rat-derived stem cells

JANUARY 5, 2024byNara Institute of Science and TechnologyA rat embryonic stem cells derived lung generated within a mouse body stained with epithelial cells (labeled with E-cadherin, shown in gr
Pulmonology March 25,2024
Controlling inflammation to conquer lung infection

Controlling inflammation to conquer lung infection

JANUARY 16, 2024byHudson Institute of Medical ResearchLAT8881 and LAT9997 improve resistance to influenza A virus infection in vivo. A, Schematic of human growth hormone structure (orange; http:
Pulmonology March 25,2024
Controlling inflammation to conquer lung infection

Controlling inflammation to conquer lung infection

JANUARY 16, 2024byHudson Institute of Medical ResearchLAT8881 and LAT9997 improve resistance to influenza A virus infection in vivo. A, Schematic of human growth hormone structure (orange; http:
Pulmonology March 25,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com